Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harvest Technologies, a subsidiary of Terumo BCT, is a pioneer in the development of point-of-care platforms for isolating and concentrating autologous growth factors and stem cells. The company is best known for its SmartPrep Multicenter System, which is used by clinicians to prepare Platelet-Rich Plasma (PRP), Bone Marrow Aspirate Concentrate (BMAC), and adipose tissue concentrates. These concentrated biologics are utilized to accelerate healing in various clinical settings, including orthopedics, sports medicine, and chronic wound management. By providing a rapid, automated, and reproducible method for cell processing, Harvest Technologies has established itself as a leader in the regenerative medicine market. The company's technology is designed to be used directly in the operating room or office setting, facilitating immediate application of the patient's own cells. Since its acquisition by Terumo BCT in 2012, the Harvest product line has been integrated into a global portfolio of blood component and cellular technology solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harvest SmartPrep.